Neuraease is a neurotechnology research and AI-driven health innovation company focused on predictive stress detection and behavioral health insights.

We integrate wearable biometrics, physiological signal processing, and machine learning to identify early indicators of stress dysregulation - particularly in neurodivergent populations such as Autism and ADHD cohorts.

Our modular platform combines:
• Biometric data capture
• Scalable health data infrastructure
• AI-powered predictive modeling
• Clinically informed insight layers

Neuraease is building toward translational validation through structured pilot studies and defined biomarker outcome metrics, supported by a growing clinical advisory network in the United States.

Our mission is to move from reactive symptom management to proactive stress prediction—enabling earlier interventions, reduced anxiety episodes, and improved daily functioning.

We are advancing research at the intersection of neurotechnology, digital health, wearable hardware engineering, and artificial intelligence to create measurable impact in behavioral healthcare, with a north star of improving overall well-being of neurodivergent people.

NeuraEase

Org chart

Teams

Offices